from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1241/vapB33

LFCtreatmentdescriptionclass of inhibitor

-0.143

Amikacinug/mL Amikacintranslation

1.232

Cap5-10ug/mL Capreomycintranslation

1.712

Rox10-50 ug/mL Roxithromycintranslation

1.328

SM2-5 ug/mL Streptomycintranslation

0.105

Tet5-10 ug/mL Tetracyclinetranslation

0.223

Rif0.2-5ug/mL Rifampicintranscription

-0.267

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.567

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.522

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.918

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.512

Clofazimine10-13 ug/mL Clofaziminerespiration

0.488

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.159

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.377

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.156

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.422

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.122

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.842

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.771

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.490

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.992

KCN5-20 ug/mL Potassium cyaniderespiration

0.094

NaN30.2-2 mM Sodium aziderespiration

1.099

Nigericin50 uM Nigericinrespiration

-0.855

TRC10-150 ug/mL Triclosanrespiration

-1.711

TRZ10-25 ug/mL Thioridazinerespiration

-0.886

Valinomycin0.5-10 uM Valinomycinrespiration

1.183

ZnSO42 mM ZnSO4respiration

-0.550

menadione6-10 ug/mL Menadionerespiration

0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.083

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.270

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.198

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.219

NRP_1Non-replicating persistence stage 1dosRassociated

0.489

Amp0.2mg/mL AmpicillincellWall

0.367

Cephalexin20-100 ug/mL CephalexincellWall

1.259

Cerulenin0.32-5 ug/mL CerulenincellWall

0.522

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.563

EMB10-20 ug/mL EthambutolcellWall

0.834

Eta12-40 ug/mL EthionamidecellWall

1.186

INH0.2-0.4 ug/mL IsoniazidcellWall

0.598

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.422

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.152

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.420

BZA0.12 mg/mL BenzamidearomaticAmides

-0.228

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.134

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.160

H2O24 mM hydrogen peroxideDNAdamaging

0.344

Levo10 ug/mL LevofloxacinDNAdamaging

0.362

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.898

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.387

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.379

UVUV-irradiationDNAdamaging

-1.193

ARP41-4 ug/mL Antitubercular compound ARP4?

1.061

Antimycin12.5-50 ug/mL Antimycin A?

0.715

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.658

PA_110-50 ug/mL Antitubercular compound PA-1?

0.580

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.158

PA8240.2-2 ug/mL PA-824?

-1.247

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.288

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.461

Verapamil50 uM Verapamil?

0.631

mercaptoethanol2 mM 2-Mercaptoethanol?

0.911

methoxatin10-20 ug/mL Methoxatin?